Search research articles
Contact Us
Filters
Showing results (271-280 of 304) with videos related to
Page
of 31
Sort By:
Future Cardiology
|
June 23, 2025
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary
Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Clinical Chemistry
|
October 18, 2017
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
Isabelle Ruel, Sumayah Aljenedil, Iman Sadri, et al.
Journal of the American College of Cardiology
|
August 21, 2024
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results
Michelle L O'Donoghue, Robert S Rosenson, J Antonio G López, et al.
Journal of Clinical Lipidology
|
December 22, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Circulation
|
June 9, 2017
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)
Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
The New England Journal of Medicine
|
April 1, 2008
Simvastatin with or without ezetimibe in familial hypercholesterolemia
John J P Kastelein, Fatima Akdim, Erik S G Stroes, et al.
The New England Journal of Medicine
|
August 8, 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Joseph L Witztum, Daniel Gaudet, Steven D Freedman, et al.
Circulation
|
February 13, 2018
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
D Meeike Kusters, Marjet J A M Braamskamp, Gisle Langslet, et al.
Journal of Clinical Lipidology
|
December 5, 2024
Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia
Martine Paquette, Isabelle Ruel, Simon-Pierre Guay, et al.
Nature Genetics
|
December 23, 2008
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Alexandra-Chloé Villani, Mathieu Lemire, Geneviève Fortin, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 304) with videos related to
Sort By:
Page
of 31
Future Cardiology
|
June 23, 2025
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary
Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Clinical Chemistry
|
October 18, 2017
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
Isabelle Ruel, Sumayah Aljenedil, Iman Sadri, et al.
Journal of the American College of Cardiology
|
August 21, 2024
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results
Michelle L O'Donoghue, Robert S Rosenson, J Antonio G López, et al.
Journal of Clinical Lipidology
|
December 22, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Circulation
|
June 9, 2017
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)
Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
The New England Journal of Medicine
|
April 1, 2008
Simvastatin with or without ezetimibe in familial hypercholesterolemia
John J P Kastelein, Fatima Akdim, Erik S G Stroes, et al.
The New England Journal of Medicine
|
August 8, 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Joseph L Witztum, Daniel Gaudet, Steven D Freedman, et al.
Circulation
|
February 13, 2018
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
D Meeike Kusters, Marjet J A M Braamskamp, Gisle Langslet, et al.
Journal of Clinical Lipidology
|
December 5, 2024
Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia
Martine Paquette, Isabelle Ruel, Simon-Pierre Guay, et al.
Nature Genetics
|
December 23, 2008
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Alexandra-Chloé Villani, Mathieu Lemire, Geneviève Fortin, et al.
Page
of 31